Source link : https://newshealth.biz/health-news/t-dxd-moves-into-curative-setting-in-her2-positive-breast-cancer/
(MedPage Today) — The DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) trials, presented at the European Society for Medical Oncology (ESMO) congress, showed that the inclusion of neoadjuvant or adjuvant trastuzumab pathologic complete response… Source link : https://www.medpagetoday.com/meetingcoverage/esmovideopearls/118444 Author : Publish date : 2025-11-11 17:56:00 Copyright for syndicated content belongs to the linked Source.
The post T-DXd Moves Into Curative Setting in HER2-Positive Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-11 17:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8